NEXT Austin

Dr. Andrae Vandross is trained, and board certified in medical oncology and internal medicine. He leads the Phase 1 clinical trial group at NEXT Oncology in Austin. Dr. Vandross is experienced in comprehensive and clear discussions with advanced cancer patients who are navigating the complex decisions associated with novel therapeutics. His highest priority is patient education in the context of Phase 1 clinical trials.

BACKGROUND:

Dr. Vandross earned his medical degree from the Pritzker School of Medicine at the University of Chicago. He performed residencies in general surgery and internal medicine at Yale New Haven Hospital in Connecticut. He was a Hematology/Oncology Fellow at the University of California, Los Angeles, and an assistant clinical professor-hematology/oncology at the David Geffen School of Medicine at UCLA.

Dr. Sheena Sahota is originally from Missouri. She is a medical oncologist and hematologist. She is board certified in internal medicine, nephrology, hematology and oncology. She went to medical school at the University of Missouri-Kansas City where she completed the six year BA/MD program. From there she slowly made her way east through her various trainings including completing her internal medicine residency at Rush University Medical Center in Chicago, IL as well as her nephrology training. She worked for a year at the University of Chicago before continuing her training in Hematology/Oncology at Weill Cornell Medical Center/New York Presbyterian in New York City. Prior to joining NEXT, she was working for Stanford Healthcare and her focus was in breast cancer treatments. She is excited to be a part of the team and work in early drug development.\

Outside of work, she loves spending time with her two daughters and husband. She enjoys hiking, running, going home to Missouri and traveling the world.